This article describes a protocol for visualizing amyloid Aβ plaques in Alzheimer's disease mouse models using methoxy-X04, which crosses the blood-brain barrier and selectively binds to β-pleated sheets found in dense core Aβ plaques. It allows pre-screening of plaque-containing tissue sections prior to immunostaining and processing for electron microscopy.
A detailed protocol is provided here to identify amyloid Aβ plaques in brain sections from Alzheimer's disease mouse models before pre-embedding immunostaining (specifically for ionized calcium-binding adapter molecule 1 (IBA1), a calcium binding protein expressed by microglia) and tissue processing for electron microscopy (EM). Methoxy-X04 is a fluorescent dye that crosses the blood-brain barrier and selectively binds to β-pleated sheets found in dense core Aβ plaques. Injection of the animals with methoxy-X04 prior to sacrifice and brain fixation allows pre-screening and selection of the plaque-containing brain sections for further processing with time-consuming manipulations. This is particularly helpful when studying early AD pathology within specific brain regions or layers that may contain very few plaques, present in only a small fraction of the sections. Post-mortem processing of tissue sections with Congo Red, Thioflavin S, and Thioflavin T (or even with methoxy-X04) can label β-pleated sheets, but requires extensive clearing with ethanol to remove excess dye and these procedures are incompatible with ultrastructural preservation. It would also be inefficient to perform labeling for Aβ (and other cellular markers such as IBA1) on all brain sections from the regions of interest, only to yield a small fraction containing Aβ plaques at the right location. Importantly, Aβ plaques are still visible after tissue processing for EM, allowing for a precise identification of the areas (generally down to a few square millimeters) to examine with the electron microscope.
Amyloid Aβ plaque formation is the main neuropathological hallmark of Alzheimer's disease (AD). However increasing evidence suggests important roles of the immune system in disease progression1,2. In particular, new data from preclinical and clinical studies established immune dysfunction as a main driver and contributor to AD pathology. With these findings, central and peripheral immune cells have emerged as promising therapeutic targets for AD3. The following protocol combines light and electron microscopy (EM) to generate new insights into the relationship between Aβ plaque deposition and microglial phenotypic alterations in AD. This protocol allows the labeling of Aβ plaques in mouse models of AD using in vivo injection of the fluorescent dye methoxy-X04. Methoxy-X04 is a Congo Red derivative that can easily cross the blood-brain barrier to enter the brain parenchyma and bind β-pleated sheets with high affinity. Since the dye is fluorescent, it can be used for in vivo detection of Aβ plaque deposition with two-photon microscopy4. Once bound to Aβ, methoxy-X04 does not dissociate or redistribute away from plaques, and it retains its fluorescence over time. It is generally administered peripherally to allow for non-invasive imaging of brain dynamics5. The fluorescence also remains following aldehyde fixation, allowing for correlative post-mortem analyses, including investigation of neuronal death in the vicinity of Aβ plaques6.
This protocol takes advantage of the properties of methoxy-X04 to select brain sections from APPSWE/PS1A246E mice (APP-PS1; coexpressing a double mutation at APP gene Lys670Asn/Met671Leu, and human presenilin PS1-A264E variant)7 that exhibit Aβ plaques in specific regions of interest (hippocampus CA1, strata radiatum, and lacunosum-moleculare) prior to pre-embedding immunostaining against the microglial marker ionized calcium-binding adapter molecule 1 (IBA1) to visualize microglial cell bodies and processes with EM. The mice are given intraperitoneal injection of methoxy-X04 solution, 24 hr prior to brain fixation through transcardial perfusion. Coronal brain sections are obtained using a vibratome. Sections containing the hippocampus CA1 are screened under a fluorescent microscope for the presence of Aβ plaques in strata radiatum and lacunosum-moleculare. Immunostaining for IBA1, osmium tetroxide post-fixation, and plastic resin embedding are then performed on the selected brain sections. At the end of this protocol, the sections can be archived without further ultrastructural degradation, ready for ultrathin sectioning and ultrastructural examination. Importantly, the plaques are still fluorescent after immunostaining with different antibodies, for instance IBA1 as in the present protocol. They become darker than their surrounding neuropil following osmium tetroxide post-fixation, independently of methoxy-X04 staining, which helps to accurately identify the regions of interest, generally down to a few square millimeters, to be examined with the transmission electron microscope.
This correlative approach offers an efficient way to identify specific brain sections to examine at the ultrastructural level. This is particularly helpful when studying early AD pathology, within specific brain regions or layers that may only contain a few Aβ plaques, present in only a small fraction of tissue sections. During these times especially, it would be inefficient to use immunostaining for Aβ (and dual labeling for other cellular markers such as IBA1) on several brain sections simply to yield a small fraction containing Aβ plaques at the right location. In addition, injection of live mice with methoxy-X04 prior to sacrifice and tissue processing does not compromise the ultrastructural preservation. Alternative methods such as post-mortem staining with Congo Red, Thioflavin S, Thioflavin T or methoxy-X04 on fixed tissue sections require staining differentiation in ethanol,8-11 which causes osmotic stress and disrupts the ultrastructure. Congo Red is also a known human carcinogen12.
Note: All experiments were approved and performed under the guidelines of the Institutional animal ethics committee, in conformity with the Canadian Council on Animal Care guidelines as administered by the Animal Care Committee of Université Laval. APP-PS1 male mice between 4 and 21 months of age were used. These animals were housed under a 12 hr light-dark cycle at 22 – 25 °C with free access to food and water.
1. Methoxy-X04 Solution Preparation
2. Methoxy-X04 Solution Injection
3. Transcardial Perfusion of the Injected Mice
4. Brain Sectioning Using a Vibratome
5. Section Screening for the Presence of Methoxy-X04-stained Plaques
6. Pre-embedding Immunostaining for IBA1
Note: Perform the immunostaining for IBA1 on selected freely-floating sections by placing the plate on a slowly moving rocker at RT.
7. Processing for Electron Microscopy
This section illustrates the results that can be obtained at different critical steps of the protocol. In particular the results show examples of brain sections containing methoxy-X04 stained plaques in specific region and layers of interest: the hippocampus CA1, strata radiatum, and lacunosum-moleculare. The plaques and regional/lamellar organization of the hippocampus are successively visualized using a combination of UV and bright field filters (Figure 1). The selected brain sections are subsequently immunostained and processed for EM while keeping track of their Aβ plaques, considering that they are still fluorescent following immunostaining, and become darker than the surrounding neuropil following treatment with osmium tetroxide and embedding (Figure 1). This allows one to identify the areas (generally a few millimeters squared) to examine with the electron microscope based on the location of plaques. Furthermore, an improved protocol for pre-embedding immunostaining of microglia with IBA1 is described here. This protocol yields an exceptional visualization of microglial cell bodies, large and small processes (Figure 2) as well as penetration of the antibodies within the brain sections. It thus facilitates the identification of microglial cell bodies and processes at the ultrastructural level, and the study of their interactions with Aβ plaques (Figures 3 and 4).
Figure 1. Visualization of Aβ Plaques in 21-month-old APP-PS1 Mice Using Light Microscopy, Following Systemic Injection of the Fluorescent Dye Methoxy-X04. A-B) Dual imaging of one hippocampal section using bright field and fluorescence modes. The regions and layers of interest are visualized under bright field (A), and the Aβ plaques successively localized using an UV filter at a range of 340 – 380 nm (B). C-D) Dual imaging of another hippocampal section before (C) and after (D) pre-embedding immunostaining for IBA1, followed by post-fixation in osmium tetroxide, dehydration in ethanol, and embedding in a plastic resin as required for transmission electron microscopy. To be noted, the plaque (encircled by a dotted line) is still visible upon tissue processing for electron microscopy. Visualizing the plaques when trimming the tissue blocks allows for a precise selection of the areas to image at high spatial resolution. Scale bars = 300 μm for A and B, 150 μm for C and D. Please click here to view a larger version of this figure.
Figure 2. Visualization of Microglial Cell Body and Fine Processes in 21-month-old APP-PS1 Mice by IBA1 Staining at the Light Microscopic Level. A-B) Examples of IBA1-stained microglia showing a clustered distribution when they associate with Aβ plaques (identified by correlative fluorescence imaging of methoxy-X04; encircled by a dotted line) as observed before osmium tetroxide post-fixation and plastic resin embedding. C-D) Examples of IBA1-stained microglia associated with Aβ plaques after osmium tetroxide post-fixation and plastic resin embedding. Note that the plaques become darker than their surrounding neuropil following osmium post-fixation, thus allowing tracking of their location. Scale bar = 250 μm. Please click here to view a larger version of this figure.
Figure 3. Dual Visualization of Aβ plaques and IBA1-immunostaining in 6-month-old APP-PS1 Mice at the Ultrastructural Level. A) Example of dense core Aβ plaque recognized by its compact fibrillary structure (see inset) and association with dystrophic neurites with ultrastructural features of autophagy. B) Example of IBA1-stained microglial process (m; colored in violet) found nearby the Aβ plaque that contains amyloid deposits. Mitochondrial alterations (shown by asterisks) can also be seen within the microglial process. To be noted, this picture was acquired at the tissue-resin border (white, at the right of the picture) where the penetration of antibodies and staining intensity is maximal. Scale bars = 2 μm for A, 1 μm for B. Please click here to view a larger version of this figure.
Figure 4. Additional Examples of IBA1-immunostained Microglia in 6-month-old APP-PS1 Mice as Observed with Transmission Electron Microscopy. A-D) Examples of IBA1-stained microglial cell body and processes (m) acquired farther from the tissue-resin border, showing an excellent penetration of the antibodies and staining intensity deeper within the section using this protocol. bv=blood vessel, d=dendrite, in=inclusion, s=dendritic spine, t=axon terminal. The arrowheads show synaptic clefts. Scale bars = 1 μm. Please click here to view a larger version of this figure.
This protocol explains a correlative approach for targeting dense core Aβ plaques with EM. Methoxy-X04 in vivo injection allows rapid selection of brain sections that contain Aβ plaques within particular regions and layers of interest, for instance the hippocampus CA1, strata radiatum, and lacunosum-moleculare. In the present example, methoxy-X04 pre-screening was combined with pre-embedding immunostaining for IBA1 to study how different microglial phenotypes interact with synapses at the ultrastructural level in the presence of dense core Aβ plaques.
Microglia are incredibly responsive to their surroundings and their inflammatory activity has been long studied in the context of undermining normal brain function and enhancing the advancement of AD. In particular, these cells were implicated in neurodegenerative processes due to their extensive activation and release of pro-inflammatory cytokines, leading to chronic neuroinflammation, and disruption of normal brain homeostasis15. In recent years, however, these resident immune cells were also shown to actively remodel neuronal circuits in the healthy brain, leading to identification of new pathogenic mechanisms16,17. Their physiological roles at synapses may become dysregulated during neuroinflammation in AD, resulting in exacerbated synaptic loss, currently the best pathological correlate of cognitive decline across various neurodegenerative conditions18,19.
The modifications made to the previous pre-embedding IBA1 staining method13 now allow better penetration of antibodies across the brain sections, as well as visualization of microglial cell bodies and fine processes at the ultrastructural level. Overall, the protocol needs to be performed rigorously from mouse perfusion until plastic resin embedding of the tissue sections, considering that ultrastructural degradation occurring at any in-between step could compromise the integrity of cellular membranes, organelles, cytoskeletal elements, etc.
This protocol could be performed without any immunostaining (by omitting section 6) to solely visualize dense core Aβ plaques, but it also provides a powerful tool to study the complex mechanisms of AD pathogenesis with relation to Aβ deposition, as different antibodies may be used to focus on different cell types, including peripherally-derived macrophages, endogenous microglia, astrocytes, oligodendrocytes and their progenitors, as well as many neuronal subtypes.
Considering the in vivo injection of methoxy-X04, this protocol cannot be performed on fixed brain sections, which precludes its use with post-mortem human brain samples. Also, contrarily to immunostaining against Aβ which labels soluble and insoluble forms of Aβ, the use of dyes binding to β-pleated sheet protein structures such as methoxy-X04 only allows visualization of dense core plaques, which constitutes another limitation.
Nevertheless, important applications could include studying the roles of microglia and other various cell types, which overlap and augment their activities, and could have direct effects on plaque homeostasis and neuronal function over the course of AD pathology.
The authors have nothing to disclose.
We are grateful to Dr. Sachiko Sato and Julie-Christine Lévesque at the Bioimaging Platform of the Centre de recherche du CHU de Québec for their technical assistance. Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2014-05308, The Banting Research Foundation, and The Scottish Rite Charitable Foundation of Canada to M.E.T supported this work.
H.E.H. is recipient of a scholarship from the Lebanese Ministry of Education and Higher Education, and K.B. from the Faculté de médecine of Université Laval.
Methoxy-X04 | Tocris Bioscience | 4920 | 10 mg substrate per tablet |
Propylene glycol | Sigma Aldrich | W294004 | |
Dimethyl sulfoxide (DMSO) | Fisher BioReagents | BP231-1 | Caution: toxic |
Sodium Chloride NaCl | Sigma | S9625 | |
Sodium phosphate monobasic monohydrate | Sigma | S9638 | |
Sodium phosphate dibasic | Sigma | S0876 | |
Tris Hydrochloride | Fisher BioReagents | BP153500 | |
Acrolein | Sigma | 110221 | Caution: Toxic |
Paraformaldehyde Granular | Electron Microscopy Sciences | 19210 | Caution: Toxic |
Filter paper | Fisher | 09-790-14F | |
Peristaltic Pump with Tubing | ColeParmer | cp.78023-00 | |
Excel Winged blood Collection Set Needles 25G | Becton Dickinson | 367341 | |
Extrafine Forceps | F.S.T | 11152-10 | Tip shape: curved |
Scissors | F.S.T | 14090-09 | Tip shape: straight |
Hartman Hemostats | F.S.T | 13003-10 | Tip shape: curved |
Surgical Scissors | F.S.T | 14004-16 | Tip shape: straight |
Micro Dissecting Scissors | ROBOZ surgical store | 5818 | |
Glass scintillation vials | Fisher Scientific | 74515-20 | |
Vibrating Blade Michrotome Leica VT1000 S | Leica Biosystems | 14047235612 | |
Vibratome blades | Electron microscopy Sciences | 71990 | |
Microscope Slides | Fisher Scientific | 12-550-15 | |
24-well Tissue Culture Plates | Fisher Scientific | 353047 | |
Ethylene Glycol | Fisher BioReagents | BP230-4 | |
Glycerol | Fisher BioReagents | BP229-4 | |
Hydrogen Peroxide, 30% | J.T.BAKER | cat: 2186-01 | |
Sodium borohydride | Sigma | 480886 | |
Tris HCl | Fisher | BP153-500ML | |
Fetal bovine Serum (FBS) | Sigma Aldrich | F1051 | |
Bovine serum albumin (BSA), fraction V | Thomas Scientific | C001H24 | |
Triton X-100 | Sigma | T8787 | |
Anti IBA1, Rabbit | WAKO | 019-19741 | |
Goat Anti-Rabbit IgG | Jackson Immunoresearch | 111066046 | |
VECTASTAIN Elite ABC Kit (Standard) | Vector Labs | PK-6100 | |
3.3'-Diaminobenzidine tetra-hydrochloride (DAB) | Sigma | D5905-50TAB | Caution: toxic |
Osmium tetroxide, 4% solution | Electron Microscopy Sciences | 19150 | Caution: toxic |
Durcupan™ ACM single component A | Sigma | 44611 | Resin Caution: Toxic |
Durcupan™ ACM single component B | Sigma | 44612 | Hardener Caution: Toxic |
Durcupan™ ACM single component C | Sigma | 44613 | Plasticizer Caution: Toxic |
Durcupan™ ACM single component D | Sigma | 44614 | Accelerator Caution: Toxic |
Ethanol | LesAlcoolsdeComerce | 151-01-15N | |
Propylene oxide | Sigma | 110205 | Caution: corrosive |
Aluminum weigh dishes | Electron Microscopy Sciences | 70048-01 | |
ACLAR®–Fluoropolymer Films | Electron Microscopy Sciences | 50425 | |
Oven/Incubator | VWR |